| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 597 | 315 | 25 |
| Full Text Views | 6 | 3 | 0 |
| PDF Downloads | 5 | 4 | 0 |
Effect of a Cryopreserved Live Vaccine on Resistance in Mice with a Pre-Existing Schistosoma Mansoni Infection
Fred A. Lewis
Fred A. Lewis
Biomedical Research Institute, 12111 Parklawn Drive, Rockville, Maryland 20852
Search for other papers by Fred A. Lewis in
Current site
Google Scholar
PubMed
Search for other papers by Fred A. Lewis in
Current site
Google Scholar
PubMed
M. Stirewalt
M. Stirewalt
Biomedical Research Institute, 12111 Parklawn Drive, Rockville, Maryland 20852
Search for other papers by M. Stirewalt in
Current site
Google Scholar
PubMed
Search for other papers by M. Stirewalt in
Current site
Google Scholar
PubMed
Experiments were conducted to determine the effect of anti-schistosomal vaccine exposure on the level of pre-existing resistance in mice with a bisexual Schistosoma mansoni infection. C57BL/6 mice with light S. mansoni infections of 8 weeks duration were injected with 10 Krad-irradiated, cryopreserved and thawed schistosomules. Four weeks later the mice were exposed to normal cercariae, and adult worms collected by perfusion 6 weeks post-challenge. In 4 experiments, the baseline levels of resistance in infected mice ranged from 19% to 50% reduction in challenge worm burden (mean of 36%). Although vaccine administration slightly raised the overall level of resistance in infected mice (mean of 49%), in only 1 experiment was the increase over that in infected mice statistically significant. The levels of resistance attributed to the patent infection and vaccine exposure were not additive. Vaccine exposure had no effect on recovery of the adult worms of the primary infection.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 597 | 315 | 25 |
| Full Text Views | 6 | 3 | 0 |
| PDF Downloads | 5 | 4 | 0 |